COLL
Price
$37.72
Change
+$1.08 (+2.95%)
Updated
Oct 11 closing price
24 days until earnings call
SUPN
Price
$33.00
Change
+$1.11 (+3.48%)
Updated
Oct 11 closing price
24 days until earnings call
Ad is loading...

COLL vs SUPN

Header iconCOLL vs SUPN Comparison
Open Charts COLL vs SUPNBanner chart's image
Collegium Pharmaceutical
Price$37.72
Change+$1.08 (+2.95%)
Volume$353.15K
CapitalizationN/A
Supernus Pharmaceuticals
Price$33.00
Change+$1.11 (+3.48%)
Volume$395.92K
CapitalizationN/A
View a ticker or compare two or three
COLL vs SUPN Comparison Chart
Loading...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
COLL vs. SUPN commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a StrongBuy and SUPN is a StrongBuy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (COLL: $37.72 vs. SUPN: $33.00)
Brand notoriety: COLL and SUPN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: COLL: 91% vs. SUPN: 97%
Market capitalization -- COLL: $1.24B vs. SUPN: $1.84B
COLL [@Pharmaceuticals: Other] is valued at $1.24B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COLL’s FA Score shows that 2 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • COLL’s FA Score: 2 green, 3 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, COLL is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COLL’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 7 bullish TA indicator(s).

  • COLL’s TA Score: 4 bullish, 5 bearish.
  • SUPN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than COLL.

Price Growth

COLL (@Pharmaceuticals: Other) experienced а -9.89% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +3.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

COLL is expected to report earnings on Feb 20, 2025.

SUPN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($1.84B) has a higher market cap than COLL($1.24B). SUPN has higher P/E ratio than COLL: SUPN (1677.00) vs COLL (30.17). COLL YTD gains are higher at: 22.547 vs. SUPN (14.029). COLL has higher annual earnings (EBITDA): 308M vs. SUPN (90M). COLL has more cash in the bank: 311M vs. SUPN (255M). SUPN has less debt than COLL: SUPN (41.5M) vs COLL (674M). SUPN has higher revenues than COLL: SUPN (608M) vs COLL (567M).
COLLSUPNCOLL / SUPN
Capitalization1.24B1.84B68%
EBITDA308M90M342%
Gain YTD22.54714.029161%
P/E Ratio30.171677.002%
Revenue567M608M93%
Total Cash311M255M122%
Total Debt674M41.5M1,624%
FUNDAMENTALS RATINGS
COLL vs SUPN: Fundamental Ratings
COLL
SUPN
OUTLOOK RATING
1..100
8969
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
1175
SMR RATING
1..100
2189
PRICE GROWTH RATING
1..100
4352
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
9n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (65) in the Pharmaceuticals Other industry is in the same range as SUPN (95). This means that COLL’s stock grew similarly to SUPN’s over the last 12 months.

COLL's Profit vs Risk Rating (11) in the Pharmaceuticals Other industry is somewhat better than the same rating for SUPN (75). This means that COLL’s stock grew somewhat faster than SUPN’s over the last 12 months.

COLL's SMR Rating (21) in the Pharmaceuticals Other industry is significantly better than the same rating for SUPN (89). This means that COLL’s stock grew significantly faster than SUPN’s over the last 12 months.

COLL's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as SUPN (52). This means that COLL’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for COLL (100). This means that SUPN’s stock grew significantly faster than COLL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COLLSUPN
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
68%
View a ticker or compare two or three
Ad is loading...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+2.95%
SNDL - COLL
33%
Loosely correlated
+3.65%
SUPN - COLL
31%
Poorly correlated
+3.48%
ESPR - COLL
30%
Poorly correlated
+4.23%
ANIP - COLL
25%
Poorly correlated
+3.70%
ACET - COLL
25%
Poorly correlated
-0.71%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PETQ. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PETQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+3.48%
PETQ - SUPN
42%
Loosely correlated
-0.06%
AMPH - SUPN
35%
Loosely correlated
+2.77%
DVAX - SUPN
32%
Poorly correlated
+1.46%
AMRX - SUPN
30%
Poorly correlated
+1.30%
COLL - SUPN
28%
Poorly correlated
+2.95%
More